StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

CytoDyn's operating cash flow for the twelve months ending Aug 31, 2026 was -$22.53M. For fiscal 2026 it was -$17.25M. The highest annual figure on record is -$1.82M in fiscal 2011.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026May 31, 2026-$17.25M–
FY2025May 31, 2025-$8.77M–
FY2024May 31, 2024-$10.98M–
FY2023May 31, 2023-$25.11M–
FY2022May 31, 2022-$77.72M–
FY2021May 31, 2021-$117.57M–
FY2020May 31, 2020-$68.80M–
FY2019May 31, 2019-$50.47M–
FY2018May 31, 2018-$29.90M–
FY2017May 31, 2017-$26.73M–
FY2016May 31, 2016-$24.81M–
FY2015May 31, 2015-$12.02M–
FY2014May 31, 2014-$7.39M–
FY2013May 31, 2013-$3.39M–
FY2012May 31, 2012-$4.39M–
FY2011May 31, 2011-$1.82M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026-$7.73M–
Q4 FY2026CQ2 2026May 31, 2026-$4.93M–
Q3 FY2026CQ1 2026Feb 28, 2026-$5.52M–
Q2 FY2026CQ4 2025Nov 30, 2025-$4.35M–
Q1 FY2026CQ3 2025Aug 31, 2025-$2.45M-145.0%
Q4 FY2025CQ2 2025May 31, 2025-$5.66M–
Q3 FY2025CQ1 2025Feb 28, 2025-$4.96M–
Q2 FY2025CQ4 2024Nov 30, 2024-$3.59M–
Q1 FY2025CQ3 2024Aug 31, 2024$5.44M–
Q4 FY2024CQ2 2024May 31, 2024-$1.65M–
Q3 FY2024CQ1 2024Feb 29, 2024-$2.34M–
Q2 FY2024CQ4 2023Nov 30, 2023-$2.50M–
Q1 FY2024CQ3 2023Aug 31, 2023-$4.50M–
Q2 FY2023CQ4 2022Nov 30, 2022-$4.41M–
Q1 FY2023CQ3 2022Aug 31, 2022-$11.07M–
Q4 FY2022CQ2 2022May 31, 2022-$6.04M–
Q3 FY2022CQ1 2022Feb 28, 2022-$11.05M–
Q2 FY2022CQ4 2021Nov 30, 2021-$28.89M–
Q1 FY2022CQ3 2021Aug 31, 2021-$31.74M–
Q4 FY2021CQ2 2021May 31, 2021-$32.81M–
Q3 FY2021CQ1 2021Feb 28, 2021-$23.65M–
Q2 FY2021CQ4 2020Nov 30, 2020-$20.17M–
Q1 FY2021CQ3 2020Aug 31, 2020-$40.95M–
Q4 FY2020CQ2 2020May 31, 2020-$29.31M–
Q3 FY2020CQ1 2020Feb 29, 2020-$17.52M–
Q2 FY2020CQ4 2019Nov 30, 2019-$6.79M–
Q1 FY2020CQ3 2019Aug 31, 2019-$15.19M–
Q4 FY2019CQ2 2019May 31, 2019-$9.51M–
Q3 FY2019CQ1 2019Feb 28, 2019-$14.76M–
Q2 FY2019CQ4 2018Nov 30, 2018-$17.22M–
Q1 FY2019CQ3 2018Aug 31, 2018-$8.97M–
Q4 FY2018CQ2 2018May 31, 2018-$6.98M–
Q3 FY2018CQ1 2018Feb 28, 2018-$10.03M–
Q2 FY2018CQ4 2017Nov 30, 2017-$5.89M–
Q1 FY2018CQ3 2017Aug 31, 2017-$7.00M–
Q4 FY2017CQ2 2017May 31, 2017-$7.17M–
Q3 FY2017CQ1 2017Feb 28, 2017-$8.79M–
Q2 FY2017CQ4 2016Nov 30, 2016-$4.51M–
Q1 FY2017CQ3 2016Aug 31, 2016-$6.26M–

More CytoDyn figures

See a number that looks wrong?